BioCentury
ARTICLE | Clinical News

BPX-01: Phase IIa data

July 18, 2016 7:00 AM UTC

Top-line data from a double-blind, placebo-controlled, U.S. Phase IIa trial in 30 patients showed that once-daily 1% BPX-01 topical gel significantly reduced P. acnes bacteria from baseline to week 4....